Several studies confirmed that high preoperative serum or plasma MMP-2, MMP-9 and mainly TIMP-1 antigen levels are strong prognostic factors for patients with CRC and their determination might be useful for identification of patients with higher risk for cancer recurrence. The gene discussed is MMP2; the disease is cancer.